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Abstract
In this era of whole-genome, next-generation sequencing, it is important to have a
clear understanding of the concept of “haplotype”. We show here that most of the
important regions of the genome can be described in terms of polymorphic frozen
blocks (PFB). At each PFB, there are numerous, even hundreds, of alternative ancestral
haplotypes. Haplotypes, not genes, can be regarded as the principal unit of inheri‐
tance. We illustrate how sequence data can be analysed to reveal and define these
ancestral haplotypes.
Keywords: Ancestral haplotypes, Polymorphic frozen blocks, Genomic evolution
1. Introduction
Comparative analyses of haplotype sequences allow many efficiencies. It is not surprising that
there are many enthusiastic claims. Haplotypes, by any of many definitions, offer opportuni‐
ties to understand the inheritance of polymorphic traits and their regulation. The most useful
are markers of extensive complex polymorphic sequences of evolutionary significance even
when the functional components, whether coding or noncoding, are yet to be elaborated.
Substantial advances became possible with the elucidation of genomic structure and function
more than 20 years ago and long before recent advances in sequencing technology [1] and
bioinformatics [2]. It became clear that haplotypes, not genes, can be regarded as the principal
unit of inheritance.
This chapter evaluates some competing strategies and illustrates the power now available
through NGS.
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
2. Haplotype terminology
A review of current literature reveals a staggering collection of terms synonymous with











Even if it were possible to define the various neologisms, it seems certain that confusion will
remain until there is recognition of the conceptual background.
We introduced the term ancestral haplotypes to emphasise the persistence of the founding pool
[3, 4]. Such haplotypes are conserved over thousands of generations; they allow identification
of remote ancestors and their contributions to the creation of individual members of the species
with their diseases. Unfortunately, others use the same term in different ways and even in the
opposite sense, that is, to refer to the single original haplotype which is presumed to have
mutated to give rise to all the so-called variants now present. Indeed, as just one example of
the problem, the reader has to be able to interpret the following: "we identified all nonredun‐
dant haplotypes with a frequency of ≥10% and consisting of at least 10 SNPs, which are likely
to represent the nonrecombinant descendants from a single ancestor" [5].
To yet further confound matters, increasingly, the term haplotype is being used to describe any
combination of alleles or markers, such as SNPs, without regard to their reproducibility,
inheritance, polymorphism or biological significance. Currently, there are conflicting methods
of detection. The problems appear to be increasing as ephemeral concepts diverge and as
claims for better approaches focus on just one or another competing technology or bioinfor‐
matic package.
Several other aspects are clear.
• Linkage groups relate to closely linked loci but do not define haplotypes.
• Linkage disequilibrium is affected by relative frequencies and therefore fails to detect rare
haplotypes.
• Trios can be misleading since the coverage of the family is limited.
• Haplobanks. The Tokunaga group has established some important principles with the
intention of establishing haplotype-matched pluripotential stem cell banks [6]. Unfortu‐
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nately, and amazingly, there is now uncertainty as to how to define the haplotypes. For
example, a recent paper urges international collaboration to avoid fragmentation [7]. It
would be wise to avoid neologisms and such redefinitions without clarity of meaning.
3. Definitions and concepts
In the presequencing era, there was a clear understanding of what was meant by the term
haplotype: Combinations of alleles at different loci segregating together in multigenerational
family studies [8]. Some seem unaware of this long history and have had to rediscover the
concept [2].
The implications were apparent at least 50 years ago: a specific allele A1 at locus A is inherited
together with a specific allele B1 at an adjacent, “closely linked” locus B [9]. The fact that these
two alleles segregated together through multiple generations was unexpected and lead to
controversy but, in retrospect, clearly implied that
1. The two alleles were encoded on the same chromosome, whether paternal or maternal.
2. The two loci were closely linked.
3. Recombination was rare.
4. The two loci arose by duplication.
5. Duplication is associated with polymorphism.
The repeated cosegregation of alleles came to be known as a haplotype: from άπλφούς =
single [9].
It  is  worth  emphasizing  that  it  was  the  cosegregation  as  haplotypes  through  “phased”
multigenerational families (rather than “unphased” populations) which foretold the later
demonstration that there was a continuous haplospecific sequence. It is also pertinent, with the
benefit of hindsight and in view of recent confusion, that the haplotypes, defined in one family,
occurred in other families of similar remote ancestry raising the radical possibility of conserva‐
tion beyond that expected from close linkage alone. In other words, recombination is patchy
and does not necessarily disperse the components of duplications, even after thousands of
meioses. The issue of linkage disequilibrium and the limits of LD mapping are considered below.
The implications of haplotypes, as listed above, became even clearer as the HLA A and HLA
B locus alleles and then HLA DR alleles were defined during the 1970s. However, in this case,
the loci were widely separated. Over time, it became clear that each of the A-B and B-DR
haplotypes were some 800 kb in length. Patently, close linkage could not explain these
haplotypes; either there was selection for cis interaction or there was suppression of recombi‐
nation [3, 4].
Through their studies of diseases, the Alper–Yunis group discovered that the B-DR haplotypes
contained specific alleles at duplicated loci which had no structural or functional relevance to
HLA (i.e. complement and 21 hydroxylase loci) but which happen to be located within the
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major histocompatibility complex [10–16]. Thus, cis interaction alone could be rejected as the
sole explanation.
The importance of discovery through disease was illustrated at a meeting held in 1982 [3, 4].
As shown in Table 2, it was disease associations which allowed the initial discovery of ancestral
haplotypes; note, these three disease-associated haplotypes could have only been discovered
through their associations. Two share DR3 and two share B18 but the frequencies differ. Thus,
the three haplotypes cannot be detected by linkage disequilibrium.
Designation A Cw B Bf C2 C4A C4B DR Disease
8.1 1 7 8 S C Q0 1 3 MG, SLE, IDDM
18.2 – – 18 F1 C 3 Q0 3 IDDM
18.1 25 – 18 S Q0 4 2 2 C2 deficiency
MG = myasthenia gravis, SLE = systemic lupus erythematosus, IDDM = insulin-dependent (type 1) diabetes mellitus.
Adapted from ref. [4]
Table 2. MHC haplotypes and disease associations
Once the numerous other ancestral haplotypes were defined, multigenerational family studies
identified cosegregating combinations of multiple alleles at separated loci, i.e. haplotypes
stretching over nearly 2 Mb from HLA A to DR. A haplotype was defined by the alleles
“inherited en bloc from one parent and implies the transmission of all of the chromosomal
segment” from one generation to the next [4].
When haplotypes defined in one family were compared with those identified in apparently
unrelated families, sharing was immediately apparent. There were specific combinations of
alleles at all the numerous unrelated loci as these were defined and typed. However, and
increasingly relevant today, as summarized in refs. [3, 4, 17, 18]:
1. The combinations observed are not a simple function of allele frequencies; only some of
the components inherited en bloc are in linkage disequilibrium.
2. Many haplotypes are rare combinations of frequent alleles at some loci but rare alleles at
other loci.
3. Very few alleles are entirely haplospecific.
4. Haplotype frequencies are often less than 1%.
5. The same haplotypes are found in multiple, apparently unrelated, families.
6. Many of these nonrandom combinations are associated with a disease (such as systemic
lupus erythematosus) or function (such as TNF production).
7. With a few dramatic exceptions (such as 21 hydroxylase and C2 deficiency carried by what
we now call the 47.1 and 18.1 ancestral haplotypes), the individual alleles do not explain
the haplospecific effects on disease and function.
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8. Penetrance is low. That is to say, the haplotypes are sine qua non in that they permit
particular diseases and functions but only in the presence of other genetic, infectious,
environmental, hormonal and age-related factors.
9. Recombination is rare and difficult to demonstrate even within multigenerational families
with the potential to confirm a meiotic recombinant. Nevertheless, over the life of an
ancestral haplotype—say 10, 000 meioses—there have been recombinations which have
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Adapted from ref. [18].
Figure 1. Historic recombinations of AH 8.1. The HLA-B8 allele is carried by one ancestral haplotype marked by A1,
Cw7, B8, BfS, C4AQ0, C4B1, DR3. All the haplotypes in data set 1 carrying HLA-B8 are represented. These haplotypes
have been sorted so that haplotypes that carry all alleles of 8.1 from HLA-A to DR are shown at the top of the figure,
followed by haplotypes that extend from HLA-B to DR. Telomeric recombinants are shown at the bottom. The boxed
areas represent those portions of the 8.1 ancestral haplotype that are carried by unrelated B8-containing haplotypes.
Vertical lines approximately indicate the region where historical recombination has occurred.
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Some of these points are illustrated in Figure 1. It can be seen that subjects with B8 can be listed
to show conservation but also historic recombinations between HLA A and B, between C4B
and DR, and between HLA B and Bf.
By the mid-1990s, and long before the rediscoveries of the 2000s [2], such analyses led to the
conclusion that there are polymorphic frozen blocks (PFB), as illustrated in Figure 2.
Figure 2. Ancestral haplotypes and polymorphic frozen blocks within the human major histocompatibility complex.
Each ancestral haplotype has its own unique DNA sequence which includes single nucleotide polymorphisms (SNPs),
copy number variations, segmental duplications, insertion and deletion events (indels) including retroviral and retro‐
viral-like elements (RLEs). The full length is approximately 4 Mb. Higher degrees of diversity indicated by shading
define polymorphic frozen blocks (PFB). Recombination occurs far more frequently between, rather than within, these
blocks. Mutations within blocks are effectively suppressed. Adapted from refs. [17, 20] and [21]. Reproduced with per‐
mission from ref. [22].
PFB throughout the genome are the latter-day equivalents of loci. Sequences which define
ancestral haplotypes are the equivalent of alleles. The diversity is multifactorial with contri‐





These elements all contribute to the haplospecificity of the sequence of ancestral haplotypes
as shown in Figure 3. Similar distribution of diversity has been found by many others [5, 17,
19, 20, 23, 24]. The same patterns are also found in primates [25].
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Adapted from ref. [26].
Figure 3. Sequence diversity is packaged as polymorphic frozen blocks (PFB). SNPs and indel occur in similar loca‐
tions within PFB. (a) The SNP profile after removing indels. Peaks higher than 20 SNPs per 1000 nucleotides are trun‐
cated. (b) The location of indels. Peaks higher than six indels per 1000 nucleotides are truncated. (c) The position of
indels greater than 100 nucleotides.
4. Use of ancestral haplotypes
Here, we illustrate the potential of sequence analysis, if designed to identify conserved,
extended, ancestral haplotypes. The utility depends very largely on the concept behind the
analysis. However, it also depends upon the genomic region actually sequenced and whether
it is possible to interpret the patterns in the context of the heterogeneous architecture of the
genome. Within PFB, there will be a multitude of alternative sequences to compare. In the
genome between these blocks, there is much less diversity with long stretches of monomorphic
sequence. Thus, the recent fashion for identifying homozygosity [27, 28], without regard to
diversity, shifts the focus to less informative regions of the genome. Of course, by way of
explanation for the fashion, homozygosity within PFB is much more difficult to find; the most
common ancestral haplotypes with frequencies of 0.1 will be homozygous in only 1% of the
general population. Until high-throughput NGS became available, it was necessary to examine
disease panels or consanguineous families.
The conceptual background is summarised in the following figures which contrast two
approaches. Population genetics teaches that free recombination effectively prevents the
packaging of polymorphism. The reality, designated here as quantal genomics, emphasises
clustering and conservation of polymorphism. Each haplotype is a specific sequence which
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regulates expressed genes by cis, trans or epistatic interaction. The whole sequence is conserved.
Linkage disequilibrium, when it occurs, is simply a reflection of this conservation which
includes haplotypes with alleles which are relatively common in one haplotype when com‐
pared with others. Each is ancestral, in the sense that they are shared by apparently unrelated
families separated by hundreds or even thousands of generations. It follows that the poly‐
morphisms are actively conserved and could not be a consequence of recent mutation.
Some of the implications are illustrated in Figures 4 and 5.
Population Genetics  Quantal Genomics 
Figure 4. Importance of clustering functional genes. Colours represent loci and numbers represent alleles at those loci.
On the left is the basis of the infinitesimal model used in population genetics. Loci are biallelic and can be homozygous
or heterozygous. Free recombination occurs between loci and alleles segregate independently. On the right, loci are
within polymorphic frozen blocks (PFB), shown by alignment of loci. Alleles within PFB segregate en bloc, forming
haplotypes, which are inherited intact through many generations. Important genes are carried within PFB, conserving
their cis interactions. Loci within PFB have multiple alleles, allowing for a greater degree of polymorphism clustered
within the block. There can be hundreds of ancestral haplotypes for each PFB. Trans interactions between haplotypes
increase the diversity expressed in the population. The loci shown in green and yellow are outside the PFB and follow
a pattern of inheritance similar to population genetics. De novo mutations are indicated by asterisk—on the right the
mutations occur at loci outside of conserved PFB and will have little if any consequence because truly important differ‐
ences are encoded within PFB. Monogenic diseases or traits are the partial exceptions. On the left, mutations can occur
at any loci but are generally assumed to occur at loci that were monoallelic. They may or may not be important, de‐
pending upon frequency, context, repair and heritability. Adapted with permission from ref. [22].
By 1987, it was clearly established that each ancestral haplotype has a specific content of
genomic features such as duplications and indels. These too are actively conserved and can
themselves be used as signatures for haplotypes of hundreds of kilobases and even megabases.
These observations were very difficult to explain in terms of any form of neo-Darwinism,
natural selection, random errors or population genetics as taught then and today. Rather, we
realised, the genome is not actually homogeneous but partitioned into protected quanta or PFB
[17, 22, 26, 29].
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5. Sequencing of critical genomic regions
By 1992, there was sufficient sequencing to confirm the earlier prediction that each ancestral
haplotype is actually a frozen sequence.
Figure 5. Modern haplotypes are derived from the deep past—they are ancestral haplotypes.
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Haplotype Geometric element at CL1 Length Geometric element at CL2 Length
57.1 (TC)12(TG)6(TC)14(TG)3(TC)12 94 TA (TC)18 TT (TC) 9 58
18.2 (TC)14 28 Deleted
8.1 (TC)28 56 (TC)15 TG (TC)6 TG (TC)8 TG (TC)5 96
7.1 (TC)12(TG)6(TC)14(TG)3(TC)12 94 (TC)14 TG (TC)6 TG (TC)8 TG (TC)5 94
Adapted from ref. [30].
Table 3. Haplospecific geometric elements. Ancestral haplotypes have specific sequence signatures at each of the
duplicons. Note in 18.2, the duplication did not occur or has been deleted.
We now know that examples of the 8.1 ancestral haplotype are almost identical over megabases
[31, 32].
We illustrate the differences between different haplotype sequences in Figure 6. It can be seen
that there are certain sites where haplotypes differ. Importantly, haplospecificity is conferred
by the whole sequence rather than single nucleotide polymorphisms. For example, reading
from left to right, 8.1 and 18.2 differ in T/G but not A/G, etc. Note also that some of the
differences are due to indels. Of critical importance is accurate, unmolested sequencing over
kilobases, as is now possible through NGS. It is clear, however, that assembly is hazardous
especially in areas of duplication and polymorphism. Note also, that there is no justification
for regarding one particular sequence as the reference. Rather, it is necessary to compare each
output with a library of known sequences within each PFB.
The number of differences depends on which haplotypes are compared (see Table 4). Two of
the most common Caucasian haplotypes, 8.1 and 7.1, differ by a hundred positions, repre‐
senting approximately 1% nucleotide diversity. The most different haplotypes are 18.2 and 7.1,
having 2.5% nucleotide diversity. Interestingly, these haplotypes are different functionally;
18.2 permits insulin-dependent diabetes mellitus whereas 7.1 is protective.
AH Haplotype 44.2 62.1 7.1 44.1* 8.1
44.2 0
62.1 187 0
7.1 249 221 0
44.1* 73 154 227 0
8.1 224 219 101 204 0
18.2* 184 130 250 137 245
Table 4. Pairwise differences between haplotypes. Total differences between each pair of haplotypes in the 9277 bp
region at HLA-B.
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44.2 C A G A T G A G G A C C A G G G T G T G G T G T A G A G G C A G A G G G A T C T T G G T G G T T C T G T G G C C C A - A T A T A C A A C T T T A T G A A C T T G
62.1 . . . G . . . . C . . . . . . A . . . . C . . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . - . . . . . . . . . . . . . . . . . T . . .
7.1 . . T G . . . . . . . . . . . . . . . . . C . . . . G . . . . . . . . . . . . C C . . . . C . . . . . . A . . . . . G . . . . . . G . . . . . C . . . . T G . .
44.1* . . . G . . . . C . . . . . . A . . . . C . . . . . G . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . - . . . . . . . . . . . . . . . . . T . . .
8.1 . . T G . . . . . . . . . . . . . . . . . C . . . . G . . T . . . . . . . . . C C . . . . C . . . . . . A . . . . . G . . . . . . G . . . . . . . . . . T G . .
18.2* . . . G . . . . C . . . . . . A . . . . C . . . . . G . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . - . . . . . . . . . . . . . . . . . T . . .
44.2 T G T G G G C - - G T C T G C C C A T C C T T A A A C A G A G T G G T T C C C A A T C T A T A G G G G C G G A A C C C A G T A T T A T G C G G T G A G A T G T G
62.1 . . C . . . . G A . . . . A . . . . G . . . . C . . . . . G . . . . C . . . . . . . . . . . . . . . . T . . . . . . . . . A . . . . . . . . . . . . . . C . . .
7.1 . . C . . . . G A . . . . A . . . . G . . . . . . . . . . G . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . C A . .
44.1* . . . . . . . G A . . . . . . . . . G . . . . C . . . . . G . . . . C . . . . . T - . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . C . . .
8.1 . . C . . . T G A . . . . A . . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . G . . . . . . . . . T . . . . . . . . . . . . . . . . . . . C A . .
18.2* . . . . . . . G A . . . . . . . . . G . . . . C . . . . . G . . . . C . . . . . T - . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . C . . .
44.2 G G T G C T C C A G C C T C G A C C C A G G A G A T G G G G T T A C G T G G G G C C T G G T C T G G A G G T T C A G T T T T G T G C C T C A T C C G T G C T T G
62.1 . . . . T . . . . . . . . . A . . . . . . . . . . . . . . T . . . . A . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . .
7.1 . . . . . . . . . . . . . . A . . . . T . . . . G . . . . . . . . . . . . . . A . . . . . . . . . - - - . . . . . . . . . G . . . . T . . . . . . A . . . C . .
44.1* . . . . T . . . . . . . . . A . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . A . . . . . .
8.1 . . A . . . . . . A . . . . A . . . . T . . . . G . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . .
18.2* . . . . T . . . . . . . . . A . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . A . . . . . .
44.2 C T C A T A C T T C C T G A A C C C A G C T A C T T G C C T T C C T G G T G A A T G T G C C C C C T C C T C C A C C C A T C T T T C G T C C A C C A A C G T C C
62.1 . . . . . . . C . . . . A . . . . A G - . . . . C C . . . C . . . . A . . . . G . . . . T . . . . . . T . . . . T . . . . T . . . . . . . . . T . . . . . . . .
7.1 . . . . . . . C . . . . A . . . . . . . . . . . C . . . . . . . . . A . . . . G . . . . . . . . . . . . . . . . T . . . . T . . . . . . . . . . . . . . . C . .
44.1* . . . . . . . C . . . . A . . . . A G - . . . . C C . . . . . . . . A . . . . G . . . . . . . . . . . . . . . . T . . . . T . . . . . . . . . . . . . . . C . .
8.1 . . G . . . . C . . . . A . . . . . . . . . . . C . . . . . . . . . A . . . . G . . . . . . . . . . . . . . . . T . . . . T . . . . A . . . . . . . . . A . . .
18.2* . . . . . . . C . . . . A . . . . A G - . . . . C C . . . . . . . . A . . . . G . . . . . . . . . . . . . . . . T . . . . T . . . . . . . . . . . . . . . C . .
44.2 C A C G C G G T A A C T T G A G C T T C C C T C A T C C C T C A C C G C A G T G T T A T G C C C T G G T C A G A T G C A C C G C A T C T G T T G C T C C A G - - A C
62.1 . . . . . . . . . . . . . . . . . C . . . . . . G . . . . . T G . . . . C . . . . C . . . . T . . . . C . . . . . C . . . . . . . . . C . . . . . . . . . A A C . .
7.1 . . . . . . . A . . . . C . . . . C . . . . . . G . . . . . . G . . . . C . . . . C . . . . T . . . . C . . . . . C . . . . . . . . . C . . . . T . . . . A A C . .
44.1* . . T . . . . A . . . . C . . . . C . . . . . . G . . . . . . G . . . . C . . . . C . . . . T . . . . C . . . . . C . . . . A . . . . . . . . . . . . . . . A C . .
8.1 . . . . . . . . . . . . . . . . . C . . . . . . G . . . . . . G . . . . C . . . . C . . . . T . . . . C . . . . . C . . . . . . . . . . . . . . . . . . . A A C . .
18.2* . . T . . . . A . . . . C . . . . C . . . . . . G . . . . . . G . . . . C . . . . C . . . . T . . . . C . . . . . C . . . . A . . . . . . . . . . . . . . . A C . .
44.2 G A T A T T C C C T A A A A A T A G T G G C T A C C T G A T T T C T G C A A G T G C T C T A C G A T G G T C A T G A A G A A G A G G G C C G T G T
62.1 . . C . . . . T . . . . C . . . . . . . . . C . . . . - - - . . . . . . . . . . . . . . . . . . . C . . . . . G . . . . G . . . . . . . . . . . .
7.1 . . C . . . . T . . . . C . . . . A . . . . . . . . . - - - . . . . A . . . . . . . . . G . . . . C . . . . . . . . . . . . . . . A . . . . . . .
44.1* . . C . . . . T . . . . C . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . .
8.1 . . C . . . . T . . . . C . . . . . . . . . . . . . . - - - . . . . A . . . . . . . . . . . . . . C . . . . C . . . . . . . . . . . . . . . . . .
18.2* . . C . . . . T . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . . . . . C . . . . . G . . . . G . . . . . . . . . . . .
44.2 C C G C C C T G G C C G C T G A C G C C G T C C T C T C A C A T A C A G G A C A A G T A C G G T G G A C A C G G G G G T G G G C T C A G T A G T G A C T A A A
62.1 . . A . . . . . . . . A . . . . . . . . A . . . . T . . . . . . . . . A . . . . G A . . . A . . . . . . . . A A . . . . . . . . . . G . . . . . . . . . G . .
7.1 . . . . . . . . . . . A . . . . G . . . A . . . . . . . . . G . . . . A . . . . G . . . . A . . . . . . . . A A . . . . . . . . . . . . . . . C . . . . . . .
44.1* . . . . . . A . . . . A . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8.1 . . . . . . A . . . . A . . . . G . . . . . . . . . . . . . G . . . . A . . . . G . . . . A . . . . . . . . A A . . . . . . . . . . . . . . . . . . . . . . .
18.2* . . . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . A . . . . G . . . . . . . . . . . . . . . . . . . . A . . . . G . . . . . . . . . G . .// // //
//
// // // // // // // // //
// // // // // //
// // // // //
// // // // //
// // //
// // // // // // //
//
// // // // // // // // //
// // // // // //
21 19 120 69 7
// // // // //
7 30 55 50 98 121 44
//// // // // // //
// // //
// // // // // // //
// // // // // //
// // // // //
// // // // //
//
// // // // // // // // //
// // // // // //
// // //
// // // // // // //
// // // // // //
83 51 54 28 48
// // // // //
16 7 28 118 34 18 156 50 31
// // //
//
// // // // // // // // //
// // // // // //
// // // // //
// // // // //
// // //
// // // // // // //
//
// // // // // // // // //
// // // // // //
47 31 24 19 11
// // // // //
11 9 27 20 22 24 6
//// // // // // //
// // // // //
// // // // //
// // //
// // // // // // //
//
// // // // // // // // //
// // // // // //
// // // // //
// // // // //
21 7 60
// // // // // // //
11 12 32 27 5 16 7 45 12
// // // // //// // // // // //
// // // // // //
// // // // //
// // // // //
// // // // // //
// // // // // //
// // // // //
// // // // //
// // // // // //
16 21 25 19 36 79 42 25 9 17
// // // //
// // // //
// // // // // //
// // // //
// // // // // //
// // // //
// // // // // //
// // // //
// // // // // //
31 9 37 12
// // // // // //
55 62 31 55 9 6
// // // //
// // // //
// // // // // //
// // // //
// // // // // //
// // // //
// // // // // //
// // // //
// // // // // //
17 29 13 41
// // // // // //
60 39 16 14 11 29
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44.2 A C C A C T C T C C C C A C T G C C C C A C C C A C C C C C A G A C C T G C C A C C C C A C C T G C C T C C G C C C C C A T C A T G C C C G G G A C G G G C C C T C G T
62.1 . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . G . . . . A . . . . . . C . . . . T . . . . . . . . . A . . . . . . .
7.1 . . . . . . . C . . . . T . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . A . . . . . . C . . . . T . . . . C . . . . . . . . . A . .
44.1* . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8.1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18.2* . . . . . . . . . . . . T . . . . . . . C T . . - - - - - - - - - - . C . . . C . . . . G . . . . G . . . . A . . . . . . C . . . . T . . . . . . . . . . . . . . . . .
44.2 G A C C C C A A G G C A C C A A G G T G A T C C G T C T G C G T T G G A T G C T G C T T C G A G C T A G C A G G A C G G G A C G G G A A G G G G - - - - - -
62.1 . . A . . . . G . . . . T . . . . . C . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . T . . . . T . . . . T . . . . G . . . . G C T C C A
7.1 . . . . . . . G . . . . T . . . . . . . . . . . A . . . . . . . . . C . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . G . . . . - - - - - -
44.1* . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . - - - - - -
8.1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . G . . . . - - - - - -
18.2* . . A . . . . . . . . . T . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . T . . . . T . . . . T . . . . G . . . . G C T C C A
44.2 - - - - - G C A A G A G T C G G T A A G C C T G A C C A C A T G C T C T C A T G G G A C G C C T G G A C G C T C T C C T A A G G G A C A C G G C A G T A T T C T
62.1 G A A G G . . . . C . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . C . .
7.1 - - - - - . . . . . . . . . A . . . . A . . . . G . . . . G . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
44.1* - - - - - . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8.1 - - - - - . . . . . . . . . A . . . . . . . . . G . . . . G . . . . . . . . . . . C . . . . G - - . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18.2* G A A G G . . . . . . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . - - - . . . . A . . . . T . . . . . . . . . . .
44.2 A T C C C G T C C T A A G G G C C C G C G C G C T G C A G C G T C T C G T A T C G C G A C A C A G G C C T C A G C T C C A C A G C G G T G C C G C G C T C A
62.1 . . . . . . . . . . // . . . . . // . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . C A . . . . T . . . . C . . . . . . . . . . . .
7.1 . . T . . . . - . . // . . C . . // . . A . . . . . . . C . . . . T . G . . . . . . . . . C . . . . T C . . . . . C . . . . . T . . . . C . . . . G . . . . G . .
44.1* . . . . . . . . . . // . . . . . // . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G T C . . . . . . . . . . . . . . . . . . . . . .
8.1 . . . . . . . - . . // . . . . . // . . . . . . . . . . C . . . . . . G . . . . . . . . . C . . . . G T . . . . G T C . . . . . . . . . . . . . . . . . . . G . .
18.2* . . . . . . . . . . // . . . . . // . . . . . . . . . . . . . . . . . . . . . . G . . . . C . . . . G T . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
44.2 C G T C C T G G T C A T A C C A T C C T C T G G A T G A T G C C C G G C C C G T C C C C C - G A G T C T G T C G G G G - - G C G T A C G C C G G G G C G G A G C G C G G
62.1 . . G A . . . . . . . . G . . . . . . . . . . . . G . G . . . . A . . . . . . . . . . . . - . . . . T . . . . A . . . G G . . . . . . . . . A . . . . C . C . . A G . T
7.1 . . . A . . . . . . . . G . . . . G . . . . . . . G . G . . . . . . . . . A . . . . . . . - . . . . . . . . . A . . . A G . . . . . . . . . . . . . . C . C . . A G . T
44.1* . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . - . . . . . . . . . . . . . - - . . . . . . . . . . . . . . . . . . . . . . .
8.1 . . . A . . . . . T . . G . . . . G . . . . . . . G . G . . . . . . . . . . . . . . . . . C . . . . . . . . . A . . . A G . . . . C . . . . . . . . . C . C . . A G . T
18.2* . . G A . . . . . . . . G . . . . . . . . . . . . G . G . . . . . . . . . . . . . . . . . C . . . . . . . . . A . . . G G . . . . . . . . . . . . . . C . C . . A G . T
44.2 T G C G C A G G T T C T C T C G G T A A G T C T G T G T G T T G G T C T T G G A G G T C T C C C T C C T G C A T G G C G C G G C T C C T T C C T C G T G G A C A G C G T G T C G
62.1 . C . . . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . G . . A . . . . . . C . . . . T . G . . . . . .
7.1 . C . . . . . . C . . . . . . . . . C . . . . . . . . C C . G . . C . . . . T . . . . G . T . . . . . . . . . C . . . . . . . . . . . . C T . . . . C . . . . T . G . . . . . .
44.1* . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8.1 . C . . . . . . C . . . . . . . . . C . . . . . . . . . . . . . . . . . . . A . . . . G . T . . . . . . . . . C . . . . . . . . . . . . C T . . . . C . . . . T . . . . . . . .
18.2* . C . . . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . T . . . . T . . . . C . . . . G . . . . . . G . . . . . . C . . . . T . G . . . C . .
44.2 A C G G T G A C A T G G C G G T G T A G A G G G G C G A G C C C C G G G T C T C T C C T C C C C A C A C T C C C G A C C C C G C A C T C A C C G G C C A C T G C C C C C C A G
62.1 . . T . C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . . G G . . T . . . G . .
7.1 . . T . A . . . . C . . A . . . . . . . . . . . . T . . . . . T . A . . . . G . . . . . . . . G G . . . . . . . . . . . . - . . . . . . . . . . . . . . G G . . . G . . G . .
44.1* . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8.1 . . T . A . . . . . . . . . . . . . C . . . . . . . . . . . . T . A . . . . G . . . . . . . . G G . . . . . . . . . . . . - . . . . . . . . . . . . . . G G . . . G . . G . .
18.2* . . T . A . . . . C . . A . . . . . G . . . . . - . A . . . . . . . . . . . G . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . .// // // // // //
// // // // // //
// // // // // //
// // // // // //
// // // // // //
31 24 40 25 12 18
//// // // // // //
//
// // // // // // //
// // // // // //
//
// // // // // // //
// // // // // //
6 20 7 4 6 21 12
//
// //
// // // // // // // //
// // //
// // // // // // //
// // // // // //
//
// // // // // // // // //
28 36
// // // // // // // //
36 41 12 13 91 16 36
// // // //
// // // //
// // // // // //
// // // //
// // // // // //
// // // //
// // // // // //
// // // //
// // // // // //
// // // // // //
7 14 6 36 4 936 6 57 102 15 6
// // // // //// // // // // //
// // // // // //
// // // // //
// // // // //
// // // // // //
// // // // // //
// // // // //
// // // // //
// // // // // //
51 80 15 34 105 3916 163 58 20 27
// // // // // //// // // // // //
// // // // // //// // // // // //
// // // // // //// // // // // //
// // // // // //// // // // // //
// // // // // //// // // // // //
93 18 64 11 11 284 32 124 4 57 11
//
// // // // // // // // //
// //
// // // // // // // //
// // //
// // // // // // //
// // // // // //
21
// // // // // // // // //
6 26 17 69 87 52 6 12
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44.2 G A G G G C C G T G A C C C G C G A T T C T G C C C C G G C G A C A C T G A C A C C C G A C A C A A A T G G G G A C G C C A T A G G T T C G T G G A A C G C
62.1 . . C . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7.1 . . C . . . . A . . . . . A . . . . C . . . . . . G . . . . . . . G . . . . T . T . . A . T . . . . G . . . . . . . . . . . C . A . . . . A G . . . . . . .
44.1* . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8.1 . . C . . . . A . . . . . A . . . . C . . . . . . . . . . . . . . G . . . . T . T . . . . . . . . . G . . . . . . T . . . . C . A . . . . A G . . . . . . .
18.2* . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T . .
44.2 C A T T G C A G A C G C G G C C C T C G T C C G G G A C C C A - G C T G G A C C A G C C C C T T C C T C T C T C A G A - T C G A T C A C G G G G A C T C T A
62.1 . . A . . . . . . . A A . . . T . . . . . . . . . . . . . . . - . . . . C . . . . C . . G . . . . . . . . . . . . . . - . . . . . . . . . . A . . . . . . .
7.1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . G . . . . C . . . . C . . . . G . . . . . . . . . . T . .
44.1* . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . - . . . . . . . . . . . . . . . . . . . . . . . . . . . - . . . . . . . . . . . . . . . . . .
8.1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . G . . . . C . . . . C . . . . G . . . . . . . . . . T . .
18.2* . . A . . . . . . . A A . . . T . . . . C . . . . . G . . . . - . . . . C . . . . C . . G . . . . . . . . . . . . . . - . . . . . . . . . . A . . . . . . .
44.2 G G C G A T T G T C T G A A G C C A C C A C A C A G A G A T T A T T A T C T G C A A T T C C C A G A C T A T G G T G A C C C C G A C T A T A T G A G C G G G G T T
62.1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . T . . . . G . G . . . . . . . . T . .
7.1 . . T . . . . C . . . . . . . G . . . . G . . T . . G . . . . G . . . . T . . T . . . . . . . . . . . . G . . . . A . . . . T . . . . G . G . . . . . A . . . . .
44.1* . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8.1 . . T . . . . C . . . . . . . G . . . . G . . T . . G . . . . G . . . . T . . T . . . . . . . . . . . . G . . . . A . . . . T . . . . G . G . . . . . A . . . . .
18.2* . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . .
44.2 C G G G A A C C T G G G A G T G C C C G A C G C T C A A T C C G C A C A T C T A A G C A G T A T G C A T A T G G A C A C T G G G T T - A A T C T A A A A A T A C T G C C
62.1 . . . . . . . . . . C . . . G . . . . A G . . . . . . . . . T . . . . . . . C . . . . . . . G . . . . . . . . A . . . . . T . . . . - . . . . C . . . . . . . . . . . .
7.1 . . . . . G . . . . C . . . . . . . . . . . . . . G . . . . T . . . . . . . C . . . . . . . G . . . G . . . . A . . . . . T . . . . T . . . . C . . . . . . . . . . . .
44.1* . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . - . . . . . . . . . . . . . . . . .
8.1 . . . . . G . . . . C . . . . . . . . . . . . . . G . . . . T . . . . . . . C . . . . . . . G . . . G . . . . A . . . . . T . . . . - . . . . C . . . . . . . . . . . .
18.2* . . C . . . . . . . C . . . G . . . . A G . . . . . . . . . T . . . T . . . C . . . . . . . G . . . . . . . . A . . C . . T . . . . - . . . . C . . . . C . . . . A . .
44.2 A G A C T T A A A A T T C T T T C C C C C T C T C C C C C C G C T C C G T C C C C G C C T T T C A C T C C A T G T C G T C C T T C A T G T T G C A A T G T A G A T G T
62.1 . . G . . . . G . . . . . . . . . T . . . . G . . . . A . . - . C . . . . . . . T . . . . . . . . . . . . . . A . . . . T . . . . . . . . . A . . G . . . . T . . . .
7.1 . . G . . . . G . . . . . . . . . T . . . . G . . . . . . . . . . . . . . . . . . . . . . G . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . T . C . .
44.1* . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8.1 . . G . . . . G . T . . . . . . . T . . . . G . . . . . . . . . . . . . . . . . . . . . . G . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . T . C . .
18.2* . . G . . . . G . . . . . . . . . T . . . . G . . . . . . . . . . . . . . G . . T . . . . . . . . . C . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . .
44.2 A G - A A T A A G C T C A A T G T G T A A T G T A T T T T A A C C C T T T T A T T T A T T T A T T T A T T T T A T A T G G C A A A C C C T T G T C A C T C C T
62.1 . . - . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . T . . . . T . . . T . .
7.1 . . C . . . . G A . . . . G . . . . C . . . . . . . . . A . . . . . C C C . T . . . T . . . T . . - - - - . . . . G . . . . G . . . . T . . . . T . . C T . .
44.1* . . - . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8.1 . . C . . . . G A . . . . G . . . . C . . . . C . . . . A . . . . G - - - - - C C C T . . . T . . . T . . . . . . G . . . . G . . . . T . . . . T . . . T . .
18.2* . . - . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T . . C T . .
44.2 G C G C T A C C G T A T A C T T C T T A G T T T G C A C T C G C G G G G G C T T C T G C C C C T A T C A A T A T A T T A A A A T T C A A T G C A G C C
62.1 . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . G . . . . G . . . . . . . . . . . . . . . . . . . . . .
7.1 . . . . . . . . . . . . . . . . . G . . . . G . . . . T . . . . T . . . . T . . . . . . . . . . . . . . G . . . . C . . . . . . . . . G . . . . A . .
44.1* . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8.1 . . A . . . . . . . . . . . . . . G . . . . G . . . . T . . . . T . . . . T . . . . A . . . . . . . . . G . . . . . . . . . G . . . . G . . . . A . .
18.2* . . . . . . . . . . . . - . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . .// //// // // // // //
// // // // //
// // // // //
// //
// // // // // // // //
// // // // // //
// // // // //
// // // // //
// //
// // // // // // // //
// // // // // //
36 17 133 24 192
// // // // //
7 105 29 43 13 30 64 151
// // // // //// // // // // //
// // // // // //
// // // // //
// // // // //
// // // // // //
// // // // // //
// // // // //
// // // // //
// // // // // //
84 17 35 99 92 8194 84 6 69 86
// // // //
// // // //
// // // // // //
// // // //
// // // // // //
// // // //
// // // // // //
// // // //
// // // // // //
23 16 12 25
// // // // // //
12 36 20 5 4 38
// //
// // // // // // // //
// // // // // //
// //
// // // // // // // //
// // // // // //
11 18
// // // // // // // //
20 24 21 7 22 29
//
// //
// // // // // // // //
// // //
// // // // // // //
// // // // // //
//
// // // // // // // // //
28 19
// // // // // // // //
4 28 50 56 5 38 6
// // // //
// // // //
// // // // // //
// // // //
// // // // // //
// // // //
// // // // // //
// // // //
// // // // // //
// // 59 5
// // // // // //
24 33 28 45 13 34
// // // //
// // // //
// // // // // //
// // // //
// // // // // //
// // // //
// // // // // //
// // // //
// // // // // //
29 18 15 10
// // // // // //
11 9 17 36 14 14
Figure 6. Alignment of 9 kb sequence at HLA-B. Sequences of 6 individuals with homozygous ancestral haplotypes
were downloaded from UCSC browser [33] at HLA B and aligned using ClustalX2 [34]. For the purposes of illustration
only, common sequences were removed and the interruption marked as //. The nucleotides of AH 44.2 are displayed in
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the first row. Nucleotides of AH 62.1, 7.1, 44.1*, 8.1 and 18.2* are given only where they differ from AH44.2 and other‐
wise marked with a dot. Missing nucleotides are marked with a dash and shaded grey. The sequences are described by
Horton et al. [24], whereas AH haplotypes have been assigned from the HLA allele types given by Horton, according
to Cattley [35].
The degree of conservation of each ancestral haplotype is truly remarkable. For example, Smith
et al. [32] found variation at only 11 of 3, 600, 000 positions between HLA-A and DR. Similar
findings have been reported by others, including Aly et al. [31], see Figure 7. Mutation and
recombination must be suppressed.
Figure 7 illustrates the importance of interpreting nucleotide diversity according to the block
structure of the genome. Thus, conservation in the intervening, essentially monomorphic
regions, is of minor interest, whereas differences within PFB allow the discovery of evolution,
function and disease susceptibility.
Individuals 
homozygous 




for HLA DR3 
but not HLA B8 
HLAA HLAB DRB1 
  
←Telomere  Centromere→   
Adapted from ref. [31].
Figure 7. Remarkable conservation within 8.1 haplotypes. A total of 656 SNPs spanning 4.8 Mb in the MHC region are
depicted. The lower frequency allele (row) for each SNP along each haplotype column is highlighted in yellow. The
top group depicts SNP results from 8.1 AH haplotypes (n = 31), the lower group are HLA-DR3, non-B8 haplotypes (n =
13). The 29.9 Mb range between HLA and DRB1 was >99.9% conserved, with only 9 variant alleles of the 10, 768 alleles
identified for the 384 SNPs in the 31 8.1 AHs.
The inescapable conclusion is that some parts of the genome have not two or three but hundreds
of alternative ancestral sequences.
6. Sequence analysis of ancestral haplotypes
The challenge in terms of sequence analysis is to compile a sufficient matrix to be able to
recognize each haplotype and its extent. Assume access to multigenerational families with
accurate, truly phased but unmolested raw sequences of at least 100, 000 bases:
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1. Clustering of these by independent criteria relating to as many as hundreds of distinct
ancestral haplotypes.
2. Alignments which take account of haplospecific duplicons, indels and retroviral-like
elements (RLE).
3. Functional information to address biological and disease significance.
Given NGS, this approach is now feasible, even if daunting.
Importantly, those regions which are complex because of duplications and indels should be
included rather than “corrected” based on the assumption that there is a single reference or
“wild” sequence. Some examples are shown in Figure 6.
In designing better algorithms [36], the strategy for comparative analysis will be crucial. In
many polymorphic regions, the density of differences can be as high as 1 per 10 bases when
different haplotypes are compared but as low as 0 if the haplotypes are the same. It follows
that analysis without haplotype assignment will be misleading.
7. Finding polymorphic frozen blocks and their ancestral haplotypes
The best clue to the location of these blocks is segmental duplication [17, 37].
To characterize the PFB, it is helpful to amplify haplospecific geometric elements [30], see also
Table 3. Essentially, this approach reveals duplications as seen in Figure 8. McLure developed
the approach to find PFB throughout the genome [36]. Paralogous regions are also helpful as
shown in Figure 9.
Once identified, we recommend tracking the polymorphism through panels of multigenera‐
tional families as illustrated in Figure 10. Although the region is over 10 megabases, recombi‐
nation was not found. The different haplotypes in the three breeds must have been conserved
for at least hundreds of generations and mark differences in function such as the melting point
of fat [37].
8. Applications to NGS and the 1000 genomes project
8.1. Mapping PFB from 1000 genomes data
Since it is known that PFB can be mapped by plotting diversity measurements (see Figure 3),
we asked whether it would be possible to use data from the 1000 Genomes Project [39] in the
same way.
Earlier work was based on haplotypes defined in multigenerational families. Initially, sequen‐
ces of haplotypes were determined from Sanger sequencing of homozygous cell lines. In
contrast, variations in 1000 genomes are determined from NGS for heterozygous and unrelated
















Figure 8. Segmental duplications in MHC alpha block. (a) Gene families and retroelements PERB 11, HLA, HCGIV,
AD-3, HERV-16, PERB3 are duplicated to form an ordered pattern within the alpha block of the MHC, indicating that a
segment containing multiple genes and retroelements has been duplicated to give 10 duplicons. Full-length duplicons
consist of PERB11, HLA, HCGIV, 1AD3, HERV-16 (P5) and PERB3 genes. HLA-80, HLA-A, HIA-K, HLA-16, HLA-90
and HLA-F duplicons lack PERB11 gene. f = fragment, 1 = LTR only, d = discontinuous. ψ = pseudogene. A, B and C
represent subgroups of duplicons with greater similarity. (b) A dot plot of the 319 kb genomic sequence encompassing
the alpha block was compared against itself. The oblique lines in the plot represent duplications whereas the dots rep‐
resent retroelements. Lines connect regions of the dotplot to the appropriate duplicons. The primers shown amplify
products of different lengths in each duplication. Sequence from GenBank accession number AF055066. Adapted from
ref. [17].
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individuals. The phasing is an estimate based on ideas inherent in population genetics. It is
known that the approach is a risky approximation. For example, artefactual “switch-overs”
between haplotypes are misleading [40]. Since the reads tend to be short, such as just hundreds
of bases, assembly can be fraught. There is a risk of missing complex polymorphisms and
underestimating the number of ancestral haplotypes. Given these problems, we plotted several
indices related to the 1000 genomes. The intention was to identify any similarities with the
distribution as shown in Figure 3.
Unexpectedly, Figure 11 shows a remarkable correspondence between the classical measure‐
ments and our extraction from the 1000 Genomes database. The exception around 31.4 Mb was
missed by the NGS reanalysis presumably because it is a region which is rich in complex
iterative sequences, as shown in Figure 12.
These results are very encouraging in that the advantages of NGS can be coupled with
identification of genomic architecture and therefore targeting of the most informative regions.
The similarity, by simply counting the base differences per 10 kb, can be refined and applied
to the whole genome. The plot of number of “haplotypes” is also promising, although clearly
not indicative of the number of ancestral haplotypes.
6p21.3 19p13.1-13.3 1q21-25 9q33-34 6p21.3 9q33-34
MOG MPZ




VARS2 (HSPA6/7) HSPA5 C4 C5
HSPA1 VARS1 TNX HSPA5
BAT2 BAT2 exon
CYP21 CYP2 PBX2 PBX3
C4A/C4B C3 C5
NOTCH4 PSMB7
TNX TNC TNR HXB TAP2 RING3-like
PBX2 PBX1 PBX3 PSMB8 COL5A1
NOTCH4 NOTCH3 (NOTCH2) NOTCH1 TAP1 RXRA
TAP 1/2 ABC2 PSMB9
PSMB8/9 PSMB7 RING3 NOTCH1
RING3 RING3-Like COL11A2 ABC2













Figure 9. Paralogous locations of MHC genes. MHC genes are found on four chromosomes: 1, 9, 19 as well as chromo‐
some 6. The arrangements of genes in each of the paralogous groups can be largely explained by duplication with and
without inversion events. The genes common to chromosomes 6 and 9 are shown.
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8.2. Comparing polymorphic sequences of well-characterised PFB
Since there are numerous ancestral haplotypes within a PFB, it is essential to compare as many
sequences as possible. An example is shown in Figure 6.
It can be seen that
• Only a minority of sites are informative and these must be selected from the remainder.
• Kilobases need to be examined and reduced 10- to 100-fold, retaining the informative sites.
• Different haplotypes are defined by specific combinations of bases at those informative sites.
• Very few single nucleotide polymorphisms are specific for a particular ancestral haplotype.
On the contrary, specific combinations may be best defined by comparison with a library of
reference sequences.
• Indels are important: alignments can be misleading.
Thus, although the identification of each of the many haplotype remains challenging, the
overall patterns of informative sites are helpful in screening for PFB and for localising
haplospecific sequences.
9. Conclusion
In analysing NGS databases, we recommend:
1. Screening for PFB.
Reproduced with permission from ref. [22].
Figure 10. Tracing segregation through three generation families. The alleles at MRIP, now known as myosin phospha‐
tase Rho-interacting protein, are used to designate haplotypes within the 5.5 Mb region of bovine chromosome 19 from
SREBF1 to TCAP. Within this region, there are many genes involved in muscle development, growth and fatty acid
synthesis. For further details, see Williamson et al. [38].
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2. Alignment based on the ability to detect multiple, and even hundreds of ancestral
haplotypes.
3. Analysis must recognise that haplospecificity is confirmed by many characteristics
including RLE, indels, copy number and complex iterative sequences.
4. Analysis may be facilitated by examining paralogous regions which help to define
interactions, including epistasis.
5. Validation of results by showing segregation in multigenerational family studies.
6. Confirming  biological  significance  by  demonstrating  permissive  or  sine  qua  non
associations.
Figure 11. Regions of high sequence diversity within 1000 genomes are similar to previously identified PFB. Imputed
haplotypes in the 600 kb region surrounding HLA-B from 553 individuals were downloaded from the 1000 Genomes
browser [41]. The population groups chosen were of African, European and Asian origin (ACB, ASW, BEB, CEU, CHB
and YRI). The majority of variations recorded in the 1000 Genomes vcf files are SNPs, but some indels up to 174 bp are
recorded. For each imputed haplotype, we counted the number of differences from the reference sequence in 10 kb
sections. Indels were counted as one difference, irrespective of length. The black curve represents the maximum differ‐
ence at each 10 kb. The red lines, taken from ref. [42], show the amount of nucleotide diversity between two individual
haplotypes, counted in 100 bp sections. Haplotypes compared for this section were 44.1 to 62.1, 44.1 to 8.1 and 8.1 to
14.1. Squares show the number of LD_link [41] “haplotypes”, calculated from sets of adjacent variants in 500 bp inter‐
vals. LD link requires that variants be biallelic and only takes single nucleotide changes, not indels. Only variants with
at least two examples in the CEU and YRI populations were included.
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Figure 12. Complex iterative element. Dotplot of a 10 kb region in the MHC between MICA and MICB showing a com‐
plex iterative element. Gaudieri [42] shows high nucleotide diversity for this region which was not recorded within
1000 Genomes data. Example sequences for AH 7.1 and AH 44.1 downloaded from UCSC genome browser. Dotplot
generated with Gepard [43] using word length 10.
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